Join us for the fourth seminar in a collaborative research seminar series organised between the Cancer Research UK Barts and Manchester Centres to promote inclusive research activities.

Hosted every two months, this series aims to shine a spotlight on various equality, diversity and inclusivity topics in cancer research.

Our upcoming seminar will focus on Work-life balance in research.

Agenda

12:00-12:05 - Welcome from seminar Chair, Professor John Gribben (Professor of Medical Oncology at Barts Cancer Institute, Queen Mary University of London)

12:05-12:25 - Let's Talk About Work-life balance in research, Dr Rifca Le Dieu (Clinical Reader at BCI, Queen Mary)

12:25-12:45 - Discussion, with panel members including Dr Rifca Le Dieu, Dr Andrew Porter (Research Integrity and Training Adviser, CRUK Manchester Institute), Dr Rita Pedrosa (CRUK RadNet Postdoctoral Researcher, Barts Cancer Institute, Queen Mary)

About our Speaker

Dr Rifca Le Dieu

Dr Rifca Le Dieu is a Clinical Reader at Barts Cancer Institute, Queen Mary University of London, and Honorary Haemato-oncology Consultant at Barts Health NHS Trust. She has an active interest in clinical trials, is a member of the NCRI Hodgkin's Lymphoma subgroup, and speaks at the Lymphoma Action Management Course on relapsed Hodgkin's lymphoma.

In 2018, Dr Le Dieu moved from a research to a teaching role at Queen Mary to teach on the Biomedical Sciences programme in the University's School of Biological and Behavioural Sciences.

She is a passionate advocate for flexible working for medical staff via her dual roles as Barts Health Champion of Flexible Working and Joint Deputy Director of the Royal College of Physicians' Medical Workforce Unit. In 2020, she was recognised in the Timewise Power 50 Awards – a roll call of 50 powerful executives in the UK who work part-time or flexibly.

Find out more about Dr Rifca Le Dieu.

About the Cancer Research UK Barts Centre

The Cancer Research UK Barts Centre is a translational research centre focused on accelerating the transition of lab-based discovery science to the clinic. Placing a special emphasis on cancers of unmet need, the Centre’s research areas are focused into five key themes, ranging from cancer prevention and early diagnosis, to understanding cancer evolution and the basic biology of malignant cells and their surroundings. The Centre is a key partner in the CRUK City of London Centre, a world-class hub for cancer biotherapeutics.

Find out more on our Centre website.

About the Cancer Research UK Manchester Centre

Successfully renewed for a further five years as part of Cancer Research UK's new network of seven research centres across the UK, the Cancer Research UK Manchester Centre is a translational research centre that delivers world-leading research across five cross-cutting research themes. Our work covers five cross-cutting research themes:

Cancer Early Detection
Biomarker Sciences
Integrative Pathology
Radiotherapy Bioadaption
Experimental Cancer Medicine

Based in Withington, Manchester, the centre benefits from the strong links created with The Christie NHS Foundation Trust, the largest single-site cancer hospital in Europe, the expertise and facilities within the Cancer Research UK Manchester Institute, a core funded research institute, and The University of Manchester.

Find out more about the Centre on our website.

Let's Talk About...Work-life balance in research